肝细胞癌的二线治疗研究的进展
Ruirui Sun1, Chenrui Wu1, Yang Gou1
1Department of Hepatobiliary Surgery, the First Affiliated Hospital of Chongqing Medical University, No.1, Youyi Road, Yuanjiagang, Yuzhong District, Chongqing, 400000, China.
概括
肝细胞癌 (HCC) 治疗面临的挑战是药物耐药性. 本综述探讨了对初始治疗耐药的HCC患者的新兴二线全身疗法,旨在制定个性化策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 医学瘤学 医学瘤学
- 癌症研究 癌症研究
背景情况:
- 肝细胞癌 (HCC) 是一种普遍存在的恶性瘤,死亡率高.
- 晚期诊断限制了手术选择,需要全身治疗.
- 目前的第一线HCC疗法有效性有限,可能导致药物耐药性.
研究的目的:
- 审查最近对HCC的二线全身治疗的进展.
- 为解决药物耐药性HCC患者缺乏标准治疗选择的问题.
- 引导制定理性和个性化的二线HCC策略.
主要方法:
- 关于HCC系统治疗的最新研究的综合文献综述.
- 对临床试验数据的分析和对HCC药物耐药性机制的研究.
- 对新型治疗剂和二线治疗策略的研究结果的综合.
主要成果:
- 几种新型药物和组合疗法正在出现,用于二线HCC治疗.
- 了解耐药机制对于选择有效疗法至关重要.
- 基于患者资料和瘤特征的个性化方法显示出有希望.
结论:
- 人们越来越需要有效的二线全身治疗方法来治疗HCC.
- 未来的研究应该专注于优化这些疗法和开发预测生物标志物.
- 个性化医疗是改善耐药HCC病例结果的关键.
更多相关视频
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
398
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.8K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K